Korbinian Löbmann

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 28

Top Venues

Pharmaceutics

Molecules (Basel, Switzerland)

Molecular pharmaceutics

Physical chemistry chemical physics : PCCP

University of Copenhagen

University of Otago (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Copenhagen Apr 01 2017

Denmark

Associate Professor :: Department of Pharmacy

University of Copenhagen - Mar 31 2017

Denmark

Assistant Professor :: Department of Pharmacy

Education History

University of Otago

New Zealand

PHD :: Department of Pharmacy

Publications

Christoffer G Bavnhøj, Matthias M Knopp, Korbinian Löbmann
Effect of Drug Loading in Mesoporous Silica on Amorphous Stability and Performance. Pharmaceutics 16 (2) (2024)
Christoffer G Bavnhøj, Matthias M Knopp, Korbinian Löbmann
Effect of Drug Loading in Mesoporous Silica on Amorphous Stability and Performance. Pharmaceutics 16 (2) (2024)
Donglei Leng, Bulut Bulduk, Toni Widmer, Ole Wiborg, Manuel Sanchez-Felix, Korbinian Löbmann
Protein Based Amorphous Solid Dispersion: a Case Study Investigating Different Whey Proteins at High Drug Loading. Pharmaceutical research (2023)
Xuezhi Zhuo, Zeyneb Sener, Aleksei Kabedev, Min Zhao, Anis Arnous, Donglei Leng, Vito Foderà, Korbinian Löbmann
Mechanisms of Drug Solubility Enhancement Induced by β-Lactoglobulin-Based Amorphous Solid Dispersions. Molecular pharmaceutics (2023)
Xuezhi Zhuo, Maud Margrethe Brekstad Kjellin, Zarah Schaal, Tengyu Zhang, Korbinian Löbmann, Donglei Leng
A Comparative Study between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin. Pharmaceutics 15 (1) (2022)
Aleksei Kabedev, Xuezhi Zhuo, Donglei Leng, Vito Foderà, Min Zhao, Per Larsson, Christel A S Bergstrom, Korbinian Löbmann
Stabilizing Mechanisms of β-Lactoglobulin in Amorphous Solid Dispersions of Indomethacin. Molecular pharmaceutics 19 (11) (2022)
Shaquib Rahman Ansari, Nele-Johanna Hempel, Shno Asad, Peter Svedlindh, Christel A S Bergstrom, Korbinian Löbmann, Alexandra Teleki
Hyperthermia-Induced In Situ Drug Amorphization by Superparamagnetic Nanoparticles in Oral Dosage Forms. ACS applied materials & interfaces 14 (19) (2022)
Xuezhi Zhuo, Maud Margrethe Brekstad Kjellin, Zarah Schaal, Tengyu Zhang, Korbinian Löbmann, Donglei Leng
A Comparative Study between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin. Pharmaceutics 15 (1) (2022)
Xuezhi Zhuo, Maud Margrethe Brekstad Kjellin, Zarah Schaal, Tengyu Zhang, Korbinian Löbmann, Donglei Leng
A Comparative Study between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin. Pharmaceutics 15 (1) (2022)
Xuezhi Zhuo, Maud Margrethe Brekstad Kjellin, Zarah Schaal, Tengyu Zhang, Korbinian Löbmann, Donglei Leng
A Comparative Study between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin. Pharmaceutics 15 (1) (2022)
Nele-Johanna Hempel, Padryk Merkl, Matthias Manne Knopp, Ragna Berthelsen, Alexandra Teleki, Georgios A Sotiriou, Korbinian Löbmann
The Influence of Drug-Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles. Pharmaceutics 13 (6) (2021)
Jingwen Liu, Holger Grohganz, Korbinian Löbmann, Thomas Rades, Nele-Johanna Hempel
Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies. Pharmaceutics 13 (3) (2021)
Nele-Johanna Hempel, Padryk Merkl, Shno Asad, Matthias Manne Knopp, Ragna Berthelsen, Christel A S Bergstrom, Alexandra Teleki, Georgios A Sotiriou, Korbinian Löbmann
Utilizing Laser Activation of Photothermal Plasmonic Nanoparticles to Induce On-Demand Drug Amorphization inside a Tablet. Molecular pharmaceutics 18 (6) (2021)
Nele-Johanna Hempel, Padryk Merkl, Matthias Manne Knopp, Ragna Berthelsen, Alexandra Teleki, Anders Kragh Hansen, Georgios A Sotiriou, Korbinian Löbmann
The Effect of the Molecular Weight of Polyvinylpyrrolidone and the Model Drug on Laser-Induced In Situ Amorphization. Molecules (Basel, Switzerland) 26 (13) (2021)
Nele-Johanna Hempel, Matthias M Knopp, Korbinian Löbmann, Ragna Berthelsen
Studying the Impact of the Temperature and Sorbed Water during Microwave-Induced In Situ Amorphization: A Case Study of Celecoxib and Polyvinylpyrrolidone. Pharmaceutics 13 (6) (2021)
Nele-Johanna Hempel, Tra Dao, Matthias M Knopp, Ragna Berthelsen, Korbinian Löbmann
The Influence of Temperature and Viscosity of Polyethylene Glycol on the Rate of Microwave-Induced In Situ Amorphization of Celecoxib. Molecules (Basel, Switzerland) 26 (1) (2020)
Camilla Asgreen, Matthias Manne Knopp, Jeppe Skytte, Korbinian Löbmann
Influence of the Polymer Glass Transition Temperature and Molecular Weight on Drug Amorphization Kinetics Using Ball Milling. Pharmaceutics 12 (6) (2020)
Jacob Bannow, Lina Koren, Sharareh Salar-Behzadi, Korbinian Löbmann, Andreas Zimmer, Thomas Rades
Hot Melt Coating of Amorphous Carvedilol. Pharmaceutics 12 (6) (2020)
Wei Qiang, Korbinian Löbmann, Colin Peter McCoy, Gavin P Andrews, Min Zhao
Microwave-Induced In Situ Amorphization: A New Strategy for Tackling the Stability Issue of Amorphous Solid Dispersions. Pharmaceutics 12 (7) (2020)
Nele-Johanna Hempel, Matthias M Knopp, Ragna Berthelsen, Korbinian Löbmann
Convection-Induced vs. Microwave Radiation-Induced in situ Drug Amorphization. Molecules (Basel, Switzerland) 25 (5) (2020)
Georgia Kasten, Íris Duarte, Maria Paisana, Korbinian Löbmann, Thomas Rades, Holger Grohganz
Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations. Pharmaceutics 11 (1) (2019)
Adam Bohr, Thais Leite Nascimento, Necati Harmankaya, Johan Juhl Weisser, Yingya Wang, Holger Grohganz, Thomas Rades, Korbinian Löbmann
Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy. Molecules (Basel, Switzerland) 24 (2) (2019)
Eric Ofosu Kissi, Michael T Ruggiero, Nele-Johanna Hempel, Zihui Song, Holger Grohganz, Thomas Rades, Korbinian Löbmann
Characterising glass transition temperatures and glass dynamics in mesoporous silica-based amorphous drugs. Physical chemistry chemical physics : PCCP 21 (35) (2019)
Jernej Štukelj, Sami Svanbäck, Mikael Agopov, Korbinian Löbmann, Clare J Strachan, Thomas Rades, Jouko Yliruusi
Direct Measurement of Amorphous Solubility. Analytical chemistry 91 (11) (2019)
Michael T Ruggiero, Marcin Krynski, Eric Ofosu Kissi, Juraj Sibik, Daniel Markl, Nicholas Y Tan, Denis Arslanov, Wim van der Zande, Britta Redlich, Timothy M Korter, Holger Grohganz, Korbinian Löbmann, Thomas Rades, Stephen R Elliott, J Axel Zeitler
The significance of the amorphous potential energy landscape for dictating glassy dynamics and driving solid-state crystallisation. Physical chemistry chemical physics : PCCP 19 (44) (2018)
Jaya Mishra, Thomas Rades, Korbinian Löbmann, Holger Grohganz
Influence of Solvent Composition on the Performance of Spray-Dried Co-Amorphous Formulations. Pharmaceutics 10 (2) (2018)
Lasse I Blaabjerg, Holger Grohganz, Eleanor Lindenberg, Korbinian Löbmann, Anette Müllertz, Thomas Rades
The Influence of Polymers on the Supersaturation Potential of Poor and Good Glass Formers. Pharmaceutics 10 (4) (2018)
Anna Justina Svagan, Anette Müllertz, Korbinian Löbmann
Floating solid cellulose nanofibre nanofoams for sustained release of the poorly soluble model drug furosemide. The Journal of pharmacy and pharmacology 69 (11) (2017)

Korbinian Löbmann.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Korbinian Löbmann